# SUMATRIPTAN

NDC: 45802-598
Generic name: sumatriptan
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SPRAY
Routes: NASAL
Marketing started: 20201004

FDA application: ANDA213465

## Active ingredients

- SUMATRIPTAN: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-598"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-598
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d521807-e5ce-498d-a224-5534c5ea61fa